Botswana Vaccines Import Market -- HS Code 3002 Trade Data & Price Trend (Aug 2025)

Botswana Vaccines Import (HS 3002) Key Takeaways

Botswana's Vaccines Import under HS Code 3002 in August 2025 reveals a market dominated by veterinary vaccines, with South Africa supplying nearly half the value and 90% of volume, creating a high dependency risk. Supplier concentration is extreme, with top players like Hipra Southern Africa handling 97% of trade, while price volatility spiked after US tariff hikes, pushing a shift toward bulk sourcing. The product mix includes high-value human vaccines alongside standardized veterinary commodities, offering both stability and premium opportunities. This analysis, covering August 2025, is based on cleanly processed Customs data from the yTrade database.

Botswana Vaccines Import (HS 3002) Background

What is HS Code 3002?

HS Code 3002 covers human and animal blood, vaccines, toxins, and cultures. This category is critical for pharmaceutical and healthcare industries, as vaccines and blood products are essential for disease prevention and treatment. Global demand remains stable due to ongoing public health initiatives and veterinary needs.

Current Context and Strategic Position

The United States increased additional duties on all imports from Botswana to 37% effective April 2025 [Global Trade Alert]. This policy shift underscores the need for vigilance in Botswana's vaccines import market, as trade barriers could disrupt supply chains. Botswana's role in HS Code 3002 trade data is strategic, given its potential to serve regional healthcare demands. Monitoring these developments is crucial for stakeholders navigating the evolving trade landscape.

Botswana Vaccines Import (HS 3002) Price Trend

Key Observations

In August 2025, Botswana's vaccine imports under hs code 3002 were valued at $1.14 million, with a unit price of $19.03 per kg.

Price and Volume Dynamics

The Botswana Vaccines Import trend showed high volatility in 2025, with a March peak at $3.86 million followed by fluctuations. This instability aligns with the US administration's increase to a 37% additional duty on all imports from Botswana effective April 9, 2025 [Global Trade Alert], which likely prompted supply chain adjustments and a shift towards bulk sourcing. By August, the unit price dropped sharply to $19.03 per kg amid increased weight, reflecting a strategic pivot to cost-effective procurement in response to trade barriers, consistent with vaccine import cycles driven by health program needs rather than seasonal demand.

Botswana Vaccines Import (HS 3002) HS Code Breakdown

Product Specialization and Concentration

According to yTrade data for August 2025, Botswana's import market for HS Code 3002 is heavily concentrated in veterinary vaccines, specifically under sub-code 30024200, which accounts for over half of the total value and quantity. This product, described as vaccines and similar items for veterinary medicine, shows a moderate unit price of 8.48 USD per unit, indicating a specialized but not ultra-high-value segment. An extreme price anomaly is present in sub-code 30021500, with immunological products at 1167.65 USD per unit, which is isolated from the main analysis due to its outlier nature.

Value-Chain Structure and Grade Analysis

The remaining imports can be grouped into two main categories: blood-derived products and other biological preparations. Blood fractions and immunological products, such as those under sub-codes 30021200 and 30021300, form a lower-value tier with unit prices around 48-73 USD per unit, suggesting semi-finished or bulk commodities. In contrast, vaccines for human medicine and cell cultures, though minor in volume, represent higher-grade, finished goods. This structure points to a mix of standardized commodities and more differentiated manufactured items, rather than purely fungible bulk trade.

Strategic Implication and Pricing Power

For importers in Botswana, the dominance of veterinary vaccines under HS Code 3002 suggests strong pricing power for suppliers in that niche, while the high-value anomaly indicates potential for premium segments. Businesses should focus on securing reliable sources for the high-volume veterinary products and explore opportunities in specialized human medical imports, as analyzing HS Code 3002 trade data reveals a bifurcated market with both stable demand and growth in value-added areas.

Table: Botswana HS Code 3002) Breakdown Details (Source: yTrade)

Check Detailed HS Code 3002 Breakdown

Botswana Vaccines Import (HS 3002) Origin Countries

Geographic Concentration and Dominant Role

South Africa is the clear leader for Botswana's Vaccines imports in August 2025, supplying nearly half (47.91%) of the total value. This dominance is even more pronounced in volume, with South Africa accounting for 89.53% of the quantity. The fact that its value share is lower than its quantity share suggests these shipments consist of lower-cost or bulk-packaged vaccines. South Africa also handled the vast majority of transactions, with a 54.80% frequency share, confirming its role as the primary and routine supplier for Botswana's needs for HS Code 3002.

Origin Countries Clusters and Underlying Causes

The remaining partners form two distinct clusters. The first is a high-value cluster including Ireland and Switzerland; they have significant value shares (22.42% and 3.46% respectively) but minimal quantity, indicating they supply small volumes of very high-value, specialized vaccines. The second is a moderate-volume cluster featuring the Netherlands and the United States; they show a more balanced profile with notable value and quantity contributions, suggesting shipments of standard-priced vaccines. All other countries, like Germany and Spain, form a long-tail cluster with minor shares, likely representing small, niche, or spot purchases to fill specific gaps.

Forward Strategy and Supply Chain Implications

Botswana's vaccine supply chain is heavily reliant on South Africa for bulk volume, creating a significant dependency. While this ensures cost-effective supply for routine needs, it also presents a concentration risk. The strategy should involve strengthening this primary route for stability while formally engaging with the high-value cluster partners (Ireland, Switzerland) to secure access to specialized vaccines. This dual approach would build a more resilient import strategy for HS Code 3002, balancing cost-effective bulk supply with guaranteed access to critical specialty products.

Table: Botswana Vaccines (HS 3002) Top Origin Countries (Source: yTrade)

Get Complete Origin Countries Profile

Botswana Vaccines (HS 3002) Suppliers Analysis

Supplier Concentration and Dominance

In August 2025, the Botswana Vaccines Import suppliers market shows high concentration, with a single group dominating trade. According to yTrade data, high-value, frequent suppliers account for 97% of the import value, indicating that most shipments are large and regular. The typical trade involves consistent, high-volume imports, focusing on key players in this segment.

Strategic Supplier Clusters and Trade Role

The dominant high-value, high-frequency cluster includes companies like Hipra Southern Africa Pty Ltd and LIFE TECHNOLOGIES LIMITED, which appear to be direct manufacturers or specialized providers, suggesting a direct-to-factory sourcing model. A smaller cluster of low-value, high-frequency suppliers contributes minimally to value but adds frequency, with firms like ATHENESE DX PVT LTD and LGC involved. The profile of HS code 3002 suppliers points to a market driven by established, reliable partners for vaccine imports.

Sourcing Strategy and Vulnerability

Botswana's import strategy should prioritize maintaining strong ties with key high-value suppliers to ensure steady vaccine supply, but this reliance creates vulnerability to disruptions from supplier issues or external shocks. The recent US duty increase on imports from Botswana [Global Trade Alert] could strain Botswana's economy, potentially raising costs or affecting import stability, underscoring the need for contingency planning.

Table: Botswana Vaccines (HS 3002) Top Suppliers List (Source: yTrade)

Check Full Vaccines Supplier lists

Action Plan for Vaccines Market Operation and Expansion

• Use hs code 3002 trade data to secure long-term contracts with high-volume South African suppliers to lock in cost-effective pricing and ensure stability for the bulk of your Botswana Vaccines Import needs, mitigating supply chain disruption from over-reliance on a single corridor.
• Develop direct relationships with high-value suppliers in Ireland and Switzerland identified in the data to guarantee access to specialized, high-margin vaccines, diversifying your product portfolio beyond the dominant veterinary segment.
• Create a contingency plan for your Vaccines supply chain that includes identifying alternative moderate-volume suppliers in clusters like the Netherlands to immediately offset potential disruptions from the recent US duty increase on imports from Botswana.
• Monitor supplier performance and shipment frequency in the hs code 3002 trade data quarterly to proactively identify any logistical or operational issues with key partners, preventing inventory shortfalls that could halt medical programs.

Take Action Now —— Explore Botswana Vaccines Import Data

Frequently Asked Questions

Q1. What is driving the recent changes in Botswana Vaccines Import 2025 August?

The volatility in Botswana's vaccine imports is driven by a US duty increase to 37% in April 2025, prompting a shift toward bulk sourcing. By August, the unit price dropped sharply to $19.03 per kg as importers prioritized cost-effective procurement.

Q2. Who are the main origin countries of Botswana Vaccines (HS Code 3002) 2025 August?

South Africa dominates with 47.91% of import value and 89.53% of quantity, followed by Ireland (22.42%) and Switzerland (3.46%) for high-value specialized vaccines.

Q3. Why does the unit price differ across origin countries of Botswana Vaccines Import?

Price differences stem from product specialization: South Africa supplies bulk veterinary vaccines at lower costs, while Ireland and Switzerland provide high-value human medical vaccines like sub-code 30021500 at $1,167.65 per unit.

Q4. What should importers in Botswana focus on when buying Vaccines?

Importers should prioritize stable ties with high-volume suppliers like Hipra Southern Africa for bulk veterinary vaccines while securing niche partnerships with Irish/Swiss firms for specialized human vaccines to mitigate supply risks.

Q5. What does this Botswana Vaccines import pattern mean for overseas suppliers?

Suppliers from South Africa have a reliable bulk market, while Irish/Swiss firms benefit from premium demand. The US duty hike underscores the need for diversified trade routes to avoid cost shocks.

Q6. How is Vaccines typically used in this trade flow?

Vaccines under HS Code 3002 are primarily for veterinary medicine (e.g., sub-code 30024200), with smaller volumes of high-grade human medical products like immunological preparations and cell cultures.